Related Experiment Videos
Evidence-based medicine and ACE inhibition
1Department of Internal Medicine, University of Bologna, Italy.
Journal of Cardiovascular Pharmacology
|September 15, 1998
Summary
Angiotensin-converting enzyme (ACE) inhibitors offer significant benefits for cardiovascular and renal conditions. Evidence-based trials show ACE inhibitors improve blood pressure, survival rates post-myocardial infarction, and prevent heart failure development.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Angiotensin-converting enzyme (ACE) inhibitors are widely used for cardiovascular and renal conditions.
- Evidence-based medicine supports their efficacy through large clinical trials.
Purpose of the Study:
- To review the established and emerging benefits of ACE inhibitors in various cardiovascular and renal diseases.
- To highlight their role in hypertension, heart failure, myocardial infarction, and diabetic cardiovascular events.
Main Methods:
- Review of data from large-scale clinical trials.
- Analysis of evidence supporting ACE inhibitor use in hypertension, heart failure, myocardial infarction, and diabetes.
Main Results:
- ACE inhibitors improve blood pressure control in hypertension.
- They enhance survival in acute myocardial infarction and prevent chronic heart failure.
- Beneficial effects extend to diabetic patients, reducing major cardiovascular events.
Conclusions:
- ACE inhibitors are crucial for managing cardiovascular and renal diseases.
- Their broad efficacy supports their role in current and future therapeutic strategies.
- The renin-angiotensin system is a key target for vascular disease treatment.